Clinical evaluation of serum p53 antibodies in patients with upper urinary tract tumors

Journal of Urology

Volumn 174, Issue 1, 2005, Pages 73-75

  Watanabe, Jun ^a   Nishiyama, Hiroyuki ^a   Kawanishi, Hiroaki ^a   Ito, Masaaki ^a   Kamoto, Toshiyuki ^a   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Carcinoma, transitional cell; Protein p53; Serum; Tumor markers, biological; Urinary tract

Indexed keywords

ANTIBODY; P53 ANTIBODY; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINARY TRACT TUMOR;

EID: 20444480176     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000162053.44205.6e     Document Type: Article

References (18)

1. Levine, A. J.: p53, the cellular gatekeeper for growth and division. Cell, 88: 323, 1997
2. Esrig, D., Spruck, C. H., 3rd, Nicholes, P. W., Chaiwun, B., Steven, K., Groshen, S. et al: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol, 143: 1389, 1993
3. Soussi, T.: p53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res, 60: 1777, 2000
4. Dalbagni, G., Genega, E., Hashibe, M., Zhang, Z.-F., Russo, P., Herr, H. et al: Cystectomy for bladder cancer: a contemporary series. J Urol, 165: 1111, 2001
5. Highman, W. J.: Transitional carcinoma of the upper urinary tract: a histological and cytopathological study. J Clin Pathol, 39: 297, 1986
6. Smith, N. D., Rubenstein, J. N., Eggener, S. E. and Kozlowski, J. M.: The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol, 169: 1219, 2003
7. Rey, A., Lara, P. C., Redondo, E., Valdes, E. and Apolinario, R.: Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival. Cancer, 79: 2178, 1997
8. Furihata, M., Ohtsuki, Y., Sonobe, H., Shuin, T., Yamamoto, A., Terao, N. et al: Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter. Br J Cancer, 77: 783, 1998
9. Wunderlich, H., Hindermann, W., Huller, M., Reichelt, O., Werner, W., Schubert, J. et al: The correlation of p53 protein overexpression and p53 antibodies in serum of patients with transitional cell carcinoma of the urinary bladder. Urol Int, 64: 13, 2000
10. Morita, T., Tachikawa, M., Kumamaru, T., Nukui, A., Ikeda, H., Suzuki, K. et al: Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder cancer patients. Eur Urol, 37: 79, 2000
11. Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. V. P., Kennedy, B. J., Murphy, G. P. et al: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997
12. Shimada, H., Ochiai, T., Nomura, F. and Japan p53 Antibody Research Group: Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group. Cancer, 97: 682, 2003
13. Kakehi, Y., Ozdemir, E., Habuchi, T., Yamabe, H., Hashimura, T., Katsura, Y. et al: Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas. Jpn J Cancer Res, 89: 214, 1998
14. Bourhis, J., Lubin R., Roche, B., Koscielny, S., Bosq, J., Dubois, I. et al: Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst, 88: 1228, 1996
15. Shimada, H., Nabeya, Y., Okazumi, S., Matsubara, H., Funami, Y., Shiratori, T. et al: Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. Surgery, 132: 41, 2002
16. Angelopoulou, K., Stratis, M. and Diamandis, E. P.: Humoral immune response against p53 protein in patients with colorectal carcinoma. Int J Cancer, 70: 46, 1997
17. Rainov, N. G., Dobberstein, K. U., Fittkau, M., Bahn, H., Holzausen, H. J., Gantchev, L. et al: Absence of p53 antibodies in sera from glioma patients. Clin Cancer Res, 1: 775, 1995
18. Wurl, P., Fittkau, M., Meye, A., Bartel, F., Schmidt, H., Schonfelder, M. et al: Low detection rate of p53 antibodies in sera of soft tissue sarcoma patients. Cancer Lett, 170: 199, 2001